SCHEMBL4926010

SCHEMBL4926010

COc1cccc(Nc2nc(C)c(C(=O)O)s2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.62
NPC1 O15118 7/20 0.62
HPGD P15428 4/20 0.62
KDM4E B2RXH2 6/20 0.60
SMN1; SMN2 Q16637 5/20 0.60
CCNA2 P20248 1/20 0.57
CDK2 P24941 1/20 0.57
MAPT P10636 9/20 0.56
CLK1 P49759 1/20 0.56
ALDH1A1 P00352 6/20 0.56
MEN1 O00255 6/20 0.56
KMT2A Q03164 6/20 0.56
HTT P42858 4/20 0.56
GAA P10253 2/20 0.56
POLB P06746 2/20 0.55
DHODH Q02127 2/20 0.55
PPARG P37231 1/20 0.55
NCOA2 Q15596 1/20 0.55
NCOA1 Q15788 1/20 0.55
PKM P14618 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27706920 0.85 RAB9A (0.80) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4765972 0.83 NPC1 (0.76) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL3591591 0.80 NPC1 (0.64) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4914875 0.80 MAPT (0.69) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4398771 0.79 ADORA2B (0.64) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4923310 0.79 MAPT (0.57) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4918908 0.79 MAPT (0.57) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4923308 0.79 MAPT (0.57) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL2876115 0.78 MEN1 (0.52) RAB9ANPC1HPGDKDM4ESMN1; SMN2
SCHEMBL4924626 0.78 MAPT (0.76) RAB9ANPC1HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 RAB9A 1327/4885NPC1 1803/4885HPGD 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.